Ascendis Pharma A (ASND) Other Operating Expenses (2018 - 2025)

Ascendis Pharma A (ASND) posted Other Operating Expenses of $138.5 million for Q4 2025, up 140233.01% sequentially from -$98858.9 in Q1 2024.

Ascendis Pharma A (ASND) Other Operating Expenses (2018 - 2025) Analysis & Trends

Ascendis Pharma A has reported Other Operating Expenses for 8 years, with the latest figure at $138.5 million in Q4 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to $138.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $138.5 million (changed N/A YoY) and the FY2025 annual result came in at -$997.0 million, down 1025158.24% from the prior year.
Other Operating Expenses rose to $138.5 million in Q4 2025 per ASND's latest filing, from -$98858.9 in the prior quarter.
Over five years, Other Operating Expenses peaked at $138.5 million in Q4 2025 and troughed at -$262.9 million in Q4 2021.
A 5-year average of -$15.6 million and a median of $6722.9 in 2022 frame the typical range for Other Operating Expenses.
The sharpest annual moves came in 2021 and 2024: Other Operating Expenses surged 66.02% in 2021, then sank 538.59% in 2024.
Over 5 years, Other Operating Expenses stood at -$262.9 million in 2021, then jumped by 100.0% to $8066.2 in 2022, then plunged by 33.31% to $5379.7 in 2023, then plunged by 1937.63% to -$98858.9 in 2024, then jumped by 140233.01% to $138.5 million in 2025.
According to Business Quant data, Other Operating Expenses over the past three periods registered $138.5 million, -$98858.9, and $5379.7 for Q4 2025, Q1 2024, and Q4 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Ascendis Pharma A	15.40 Bn	14.73 Bn	268.20 Mn

Download Data